Harbour Investments, Inc. Beam Therapeutics Inc. Transaction History

Harbour Investments, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$29.86 - $62.36 $2,986 - $6,236	-100 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$68.02 - $99.06 $3,401 - $4,953	-50 Reduced 33.33%	100 $8,000
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $6,540 - $13,128	102 Added 212.5%	150 $19,000
Q1 2021 May 12, 2021	BUY	$71.28 - $120.75 $3,421 - $5,796	48 New	48 $4,000

235

75.1M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.86B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.